Kursprognose für Latigo Biotherapeutics, Inc. Common Stock (LTGO)LTGOLatigo Biotherapeutics, Inc. Common Stock

Alphio's LTGO stock price prediction model matches the current Latigo Biotherapeutics, Inc. Common Stock tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.85 (-0.73%). The 1-week path is $14.16 (+1.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Latigo Biotherapeutics appears to be a good buy right now, with a current price of $15.02 and a strong analyst price target of $50, suggesting a potential upside of 233%. Additionally, the company's lead asset, LTG-001, is expected to show promising results in upcoming studies, which could drive further price appreciation. However, the main risk is its negative earnings per share of -0.41, indicating ongoing financial losses that investors should monitor closely.

Latigo Biotherapeutics, Inc. Common Stock (LTGO) last closed at $13.9499998, losing -10.23%. These facts feed the 1-day and 1-week LTGO price prediction above.